This article is authored by Pratik Arya, CEO & co-founder, Finnacle Institute.

XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 Advancing potential first-in-class ...

One of the players he sought out to help in this area was Kansas City Chiefs linebacker Leo Chenal. The Commanders and Chenal agreed to a three-year contract worth nearly $25 million. The standout ...

Loan origination volume -- $8.0 billion, marking the highest quarterly level since 2022 and a 23% increase from $6.5 billion ...

In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8® data submitted; Clene expects formal ...

Researchers developed a compound that protects the liver after small bowel resection in mice. The drug improved nutrient absorption, reduced fibrosis, and avoided systemic side effects, offering hope ...

Delivered strong full year 2025 results Completed Initial Public Offering Introduced full year 2026 guidance Fourth quarter net sales of $7.8 ...

After years on SSRIs, one man shares what it’s like to live with genital numbness, delayed orgasm, and a changed sex life.

If you don’t have the money or time for expensive Pilates classes, build your own studio at home with gear we’ve tested and trust.

Cognition vs function, what prevails historically?

Dermatologists and editors agree – these peptide serums give your skin a youthful glow.

ACI-7104 Phase 2 data and mid-2026 readout, plus FY25 cash burn and dilution risk—see key catalysts and what to do now.